Home > Insider Trading > Filing (0001567619-22-014290)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1401040	Diamedica Therapeutics Inc.	DMAC	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1887435	Ab Tomenterprise	C/O Eqt Partners Ab Box 16509 Stockholm V7 103 27		No	No	Yes	No
1938915	Thomas Koch Von	C/O Eqt Partners Ab Box 16509 Stokcholm V7 103 27		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Acquisiton	2022-07-08	207,974	$1.33	2,855,827	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Footnote

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.3025 to $1.355, inclusive. The reporting person undertakes to provide to DiaMedica Therapeutics Inc., any security holder of DiaMedica Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
These shares are owned directly by TomEnterprise AB and indirectly by Thomas Von Koch in his capacity as the board member and sole owner of TomEnterprise AB. Thomas Von Koch has the sole power to vote and dispose of these shares.